Concepedia

Mikael Segerlantz

MS

6

Publications

281

Citations

6

H-Index

2001

Active since

Affiliations

Skåne University Hospital(Current)

Lund University

Malmö University

Mikael Segerlantz is an author at Skåne University Hospital specializing in metabolic syndrome, insulin resistance, and diabetes.

ORCID

Top concepts

Publications per year

2001–2020

6

Publications

6

Growth Hormone Replacement Therapy Induces Insulin Resistance by Activating the Glucose-Fatty Acid Cycle

Margareta Bramnert, Mikael Segerlantz, Esa Laurila et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 135 citations · Full text

Inhibition of the Rise in FFA by Acipimox Partially Prevents GH-Induced Insulin Resistance in GH-Deficient Adults

Mikael Segerlantz, Margareta Bramnert, Per Manhem et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 63 citations · Full text

, , +16

Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults

Mikael Segerlantz, Margareta Bramnert, Per Manhem et al. · European Journal of Endocrinology · 2003 · 36 citations

End-of-Life Treatments in Pediatric Patients at a Government Tertiary Cancer Center in India

Jean Jacob, Jaskirt Kaur Matharu, Gayatri Palat et al. · Journal of Palliative Medicine · 2018 · 22 citations

Prescription of pain medication among older cancer patients with and without an intellectual disability: a national register study

Mikael Segerlantz, Anna Axmon, Rebecca Gagnemo Persson et al. · BMC Cancer · 2019 · 13 citations · Full text

Rows per page

1–5 of 6